You have 9 free searches left this month | for more free features.

City

Birmingham (1)

Calgary (1)

Edmonton (1)

Halifax (1)

Hamilton (1)

Houston (1)

Saint John (1)

Toronto (1)

Condition

Acute Lymphoblastic Leukemia (1)

Acute Myeloid Leukemia (1)

Chronic Myeloid Leukemia (1)

Multiple Myeloma (1)

Myelodysplastic Syndromes (1)

Myelofibrosis (1)

Overall Status

Completed (1)

Terminated (1)

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Astex Pharmaceuticals, Inc. (1)

NCIC Clinical Trials Group (1)

Collaborator

Astex Pharmaceuticals, Inc. (1)

Intervention

at9283 (2)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

at9283

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Multiple Myeloma Trial in Canada (AT9283)

Completed

Multiple Myeloma

AT9283

Calgary, Alberta, Canada
+5 more

Apr 6, 2020

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia Trial in Birmingham, Houston (AT9283)

Terminated

Acute Myeloid Leukemia
+4 more

AT9283

Birmingham, Alabama
+1 more

Jan 8, 2016